TLDR
Pharma cold room temperature control requirements are the documented controls that keep medicines, vaccines, and biologics within their approved storage range. Most refrigerated pharma products require 2°C to 8°C storage, while controlled room temperature products sit around 20°C to 25°C, but the product label always controls. Compliance means more than just cooling: it requires temperature mapping, calibrated sensors, continuous monitoring, alarms, backup power, excursion procedures, and audit-ready records aligned with WHO, CDSCO GDP, and EU GDP expectations.
What Are Pharma Cold Room Temperature Control Requirements?
A pharma cold room is not compliant simply because the thermometer reads the right number. Temperature control requirements for pharmaceutical cold rooms are a system, not a single specification. That system includes room design, validated temperature mapping, continuous monitoring with calibrated instruments, alarms that trigger before product damage occurs, backup power to protect inventory during outages, written procedures for every foreseeable failure, and documentation thorough enough to survive an audit.
The core rule is simple: the product label wins. The storage temperature range printed on the label, defined by the manufacturer based on stability data, is the binding requirement. WHO defines storage temperature as the range listed on the product label and regulatory documentation for long-term storage source. CDSCO’s GDP guidance similarly states that storage conditions should comply with manufacturer recommendations source.
So while 2°C to 8°C is the most common pharma cold room range, it is not universal. Some products need controlled room temperature. Others need frozen storage. Some must not be refrigerated at all. Getting this wrong is not just an audit finding. It can degrade the product.
A compliant pharma cold room generally needs:
A defined temperature range based on the product label
Temperature mapping before use and after significant changes
Calibrated temperature sensors and data loggers
Continuous or routine temperature recording
Sensor placement based on mapped hot and cold spots
High and low alarms with escalation procedures
Backup power or alternate storage
SOPs for receipt, storage, dispatch, excursion handling, cleaning, maintenance, and calibration
Audit-ready records and QA review
CAPA for deviations and excursions
For anyone planning a pharma cold room project in India, these requirements shape everything from the insulation thickness to the monitoring software. The room itself is just the starting point. More on designing cold storage with pharma temperature monitoring in a separate guide.
Common Pharma Storage Temperature Ranges
Before specifying a cold room, the first question is: what temperature does the product actually need? Here is a quick reference, with an important caveat that ranges vary by product, market, and manufacturer.
Term | Typical Range | Common Products | Key Caveat |
|---|---|---|---|
Refrigerated / cold storage | 2°C to 8°C | Vaccines, biologics, insulins, some diagnostics | USP defines a cold place as 2°C to 8°C source |
Controlled room temperature (CRT) | 20°C to 25°C | Many solid oral dosage forms, non-refrigerated medicines | Not the same as uncontrolled ambient storage source |
Cool storage | 8°C to 15°C | Specific labelled products only | Less common; do not assume |
Frozen storage | Around −20°C (product-specific) | Some biologics, APIs, specialty products | WHO requires qualification, monitoring, and alarms for freezer rooms source |
Ultra-low temperature (ULT) | −70°C to −80°C | Certain vaccines, cell/gene therapy products | Product-specific; not a standard cold room |
Is Colder Always Safer? No.
This is one of the most common mistakes. A product labelled “do not refrigerate” should not be moved into 2°C to 8°C storage just because refrigeration feels safer. Practitioners on Reddit have discussed this exact confusion. In one case on r/pharmacy, a facility assigned a refrigerated beyond-use date to an IV product, then reversed the practice after realizing the manufacturer label did not support refrigeration source. The lesson: always check the label, monograph, or manufacturer stability data before deciding where to store a product.
A simple decision tree helps:
Does the product label say 2°C to 8°C? Use a refrigerated cold room with full monitoring.
Does it say controlled room temperature, below 25°C, or below 30°C? Do not put it in a 2°C to 8°C room unless label or stability data permits.
Does it say “do not refrigerate” or “do not freeze”? Treat refrigeration or freezing as a potential deviation.
Is the product a biologic, vaccine, or other thermolabile item? Apply stricter controls: mapping, alarms, backup power, excursion SOP, QA review.
Is the storage range unclear? Ask the manufacturer or QA team before storing.
Glossary of Key Pharma Cold Room Terms
Each term below is defined with a plain explanation and a note on why it matters in practice.
Pharma Cold Room
A temperature-controlled room used to store pharmaceutical products within their approved storage conditions. It may be designed for 2°C to 8°C, controlled room temperature, frozen storage, or other product-specific ranges. WHO treats cold rooms as temperature-controlled stores that must be qualified, monitored, alarmed, maintained, and calibrated source.
Time- and Temperature-Sensitive Pharmaceutical Product (TTSPP)
A pharmaceutical product that degrades when not stored or transported within predefined environmental conditions or time limits. WHO coined this term to cover any product where temperature or time exposure can render it unfit for use source. Why it matters: if your product is a TTSPP, every link in the cold chain counts.
Storage Temperature
The approved long-term storage range on the product label and regulatory documentation. This is the starting point for cold room design and operation. It is not a suggestion.
Temperature Excursion
Exposure outside the prescribed storage or transport temperature range. WHO notes that storage and transport ranges may differ, and both are determined by the manufacturer based on stability data source. Any excursion must be documented, investigated, and assessed for impact on the product.
Temperature Mapping
A documented study that records temperatures across a three-dimensional storage area to identify hot spots, cold spots, gradients, no-storage zones, and optimal sensor locations. WHO states that all new temperature-controlled storage areas must be mapped before commissioning, and until mapping is done, it is not safe to store TTSPPs source. Think of it as an X-ray of the room’s thermal behavior.
Hot Spot
The warmest location in the mapped storage volume. In a 2°C to 8°C room, this is the highest-risk location for breaching the upper temperature limit. Typically near doors, ceiling areas, or zones with poor airflow.
Cold Spot
The coldest location in the mapped storage volume. For freeze-sensitive products like certain vaccines and biologics, the cold spot can be more dangerous than the hot spot because accidental freezing can cause irreversible damage.
Validated Storage Volume
The space inside the cold room proven by mapping and qualification to remain within the approved temperature range. Products should only be stored within this qualified volume. WHO requires sensors and controls to maintain the validated storage volume source.
No-Storage Zone
A location inside the cold room where products should not be placed because mapping shows unacceptable risk. Common examples: directly in front of the evaporator discharge, near doors, against walls near heat-conducting surfaces. WHO explicitly requires mapping to define these zones source.
Data Logger
An electronic device that records time-temperature data at defined intervals. WHO mapping guidance specifies loggers should support sampling intervals from 1 to 15 minutes maximum, have sufficient memory, and carry a NIST-traceable 3-point calibration certificate with error not exceeding ±0.5°C source.
Continuous Monitoring
A monitoring system that records temperature repeatedly and stores a retrievable history. WHO requires cold rooms and freezer rooms to provide a temperature record at a minimum frequency of six times per hour for each monitoring sensor position source. A wall thermometer checked twice a day does not meet this standard.
Alarm Setpoint
A high or low temperature threshold that triggers an alert. WHO requires alarm systems for TTSPP cold rooms and freezer rooms, with sensors located at worst-case positions and high/low setpoints triggering visual alarms. Audible alarms and automatic phone or SMS alerts are preferred for out-of-hours response source.
Calibration
Documented comparison of a measuring instrument against a traceable standard. WHO says temperature control and monitoring devices should be calibrated against a certified traceable reference standard at least annually unless otherwise justified source. An uncalibrated sensor is just a number on a screen.
Qualification (IQ/OQ/PQ)
Documented proof that equipment or a storage area works correctly and gives expected results. EU GDP defines qualification as action proving that equipment works correctly and leads to expected results source. In practice, this typically follows three stages: Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ).
FEFO (First Expiry, First Out)
A stock rotation principle where products closest to expiry are distributed first. Both CDSCO GDP and EU GDP require this, with exceptions controlled and documented source.
CAPA (Corrective and Preventive Action)
A structured response to deviations or excursions: fix the problem and prevent it from recurring. EU GDP says deviations should be documented and CAPA principles applied where necessary source.
Backup Power
A power continuity system (UPS, generator, or alternate storage) to prevent loss of temperature control during outages. CDSCO’s biological GDP requires backup power or alternate storage in the event of power failure source. In regions with inconsistent grid power, this is not optional.
Humidity Control
Required when products are adversely affected by high relative humidity and not sufficiently protected by packaging. WHO says humidity sensors should be accurate to ±5% RH, calibrated, placed in worst-case locations, and recorded at least six times per hour source.
Audit Trail
A secure, computer-generated, time-stamped record of operator actions that create, modify, or delete electronic records. 21 CFR Part 11 requires secure audit trails for closed systems used for electronic records source. This matters because temperature data that can be silently edited is worthless to a regulator.
Quality Agreement
A written agreement defining responsibilities between parties handling storage, transport, monitoring, and deviations. CDSCO GDP calls for agreements with agencies involved in storage, transportation, and distribution source. EU GDP similarly requires written contracts for outsourced activities.
Source of Truth Temperature Record
Not a formal regulatory term, but a critical practical concept. When shipper, carrier, and receiver each run their own loggers, they can get different data. Practitioners on Reddit describe how excursion disputes become messy when the involved parties have conflicting temperature records. One r/pharmaindustry thread advises that quality agreements should define which logger is the official record, who downloads data, and how conflicting readings are reconciled source. This is an operational requirement that most compliance guides ignore.
India Requirements: CDSCO, GDP, and Schedule M Context
For pharma cold room operators in India, CDSCO expectations are the regulatory starting point. These align broadly with WHO and EU GDP principles but carry their own specifics.
CDSCO GDP for Pharmaceutical Products
CDSCO’s GDP guidance requires storage areas to be designed to ensure good storage conditions, kept clean and dry, maintained within acceptable temperature limits, and arranged so products are stored off the floor with suitable spacing for cleaning and inspection source.
For temperature control specifically, CDSCO GDP requires:
Records of storage conditions when those conditions are critical
Temperature monitoring data available for review
Defined intervals for checking temperature
Monitoring equipment checks at predetermined intervals
Retention of monitoring records for at least the product shelf life plus one year
Temperature mapping under representative conditions
Monitor placement in areas likely to fluctuate
Calibration of monitoring equipment at defined intervals
In short, CDSCO does not simply ask for a cold room. It expects controlled storage conditions, mapping, monitoring records, calibrated equipment, segregation, traceability, and documented handling of deviations.
CDSCO GDP for Biological Products
The biological products GDP guidance is stricter. It explicitly requires label-based storage conditions, alarm systems for deviations, backup power or alternate storage, and written procedures to investigate temperature excursions source. For anyone storing vaccines or biologics, these are not recommendations. They are expectations.
Revised Schedule M
India’s revised Schedule M (G.S.R. 922(E), dated 28 December 2023) has been notified source. Per a Press Information Bureau release, it became effective for manufacturers with turnover above ₹250 crore from 29 June 2024, and for manufacturers with turnover below ₹250 crore from 1 January 2026 source. This tightening of GMP standards raises the bar for temperature-controlled storage and documentation.
For pharma buyers in South India, the practical challenge is not just buying a 2°C to 8°C room. It is building a cold room that can hold the labelled range under local ambient heat, power interruptions, frequent door openings, and audit documentation expectations. Understanding how to choose a modular cold room with these requirements in mind is the first step.
Temperature Mapping Requirements
Temperature mapping is the foundation of pharma cold room temperature control requirements. Without it, there is no way to know whether the room actually maintains uniform conditions.
When Mapping Is Required
WHO’s Technical Supplement 8 is unambiguous: all new temperature-controlled storage areas must be temperature-mapped as part of a documented verification process before commissioning and handover. Until mapping is done, WHO says it is not safe to store TTSPPs in such areas source.
EU GDP also expects an initial temperature mapping exercise before use under representative conditions, with repeat mapping based on risk assessment or significant facility changes source.
What Mapping Proves
A mapping study should demonstrate:
The air temperature profile when the room is empty and when it is normally loaded
The location and severity of hot spots and cold spots
No-storage zones (near cooling coils, cold air streams, doors, heat sources)
Where routine monitoring sensors should be placed
Optionally, the time taken for temperatures to exceed limits during a power failure
For cold rooms and freezer rooms, WHO says mapping typically runs for 24 to 72 hours, or longer if justified. Ambient warehouses require at least seven consecutive days source.
Data Logger Specifications for Mapping
WHO requires loggers to provide reliable continuous time-temperature data, support sampling periods from 1 to 15 minutes maximum, have sufficient memory, carry a NIST-traceable 3-point calibration certificate with error not exceeding ±0.5°C, and allow data download for analysis. Software should comply with applicable regulatory requirements such as 21 CFR Part 11 where relevant source.
A Practical Example
In a 2°C to 8°C room, a sensor near the door may show short temperature rises during loading operations, while a sensor near the evaporator may show freezing risk. Mapping tells you whether those locations are usable storage zones or no-storage zones. Without mapping, products placed in those locations are stored on hope, not evidence.
When to Remap
Remapping or requalification is needed after:
Refrigeration equipment changes
Setpoint changes
Sensor relocation
Room layout or racking changes
Door or insulation modifications
Major repairs
Persistent unexplained variability
Significant changes in loading pattern
The practical framework: Map, identify hot and cold spots, define usable storage zones, place routine sensors, set alarm strategy, approve for use.
Monitoring and Alarm Requirements
Mapping tells you where the risks are. Monitoring tells you when something goes wrong, in time to act.
Continuous Monitoring vs. Manual Checks
WHO states that continuous recording devices are preferable because thermometers provide only limited and discontinuous temperature information source. For cold rooms and freezer rooms, the minimum recording frequency is six times per hour per monitoring sensor position. Manual review of records should happen at least twice daily, including weekends and public holidays.
Controller temperature is not enough. The controller measures air at a single point, often right at the return air duct. QA needs independent monitoring data from mapped locations that represent the actual conditions where products sit.
Sensor Requirements
WHO requires electronic monitoring sensors accurate to ±0.5°C or better, placed in locations of greatest variability as identified by mapping source. Control and monitoring systems should be independent, meaning the sensor that controls the compressor should not be the same sensor used for compliance monitoring.
Alarm Systems
WHO requires temperature alarms for cold rooms and freezer rooms, with high and low setpoints triggering visual alarms at minimum. Audible alarms and automatic phone or SMS alerts are preferred for out-of-hours situations source.
EU GDP adds that alarm levels should be appropriately set and alarms regularly tested source.
Calibration
All monitoring and control devices should be calibrated against a certified traceable reference standard at least once a year unless otherwise justified. EU GDP requires calibration traceability to national or international measurement standards source.
When specifying refrigeration units for a pharma cold room, the monitoring infrastructure (sensor ports, alarm contacts, independent sensing points) should be part of the design conversation, not an afterthought.
Backup Power, Redundancy, and Contingency Planning
Power failures are not hypothetical in many parts of India. For high-value cold chain products, the question is not whether an outage will happen, but how long the room can hold temperature when it does.
CDSCO’s biological GDP requires backup power or alternate storage in the event of power failure source. WHO expects cold rooms and freezer rooms to be connected to UPS where applicable source.
Practical considerations include:
Time-to-exceed-limit testing: how long does the room stay within range during a power failure? Mapping can include this test.
Generator or UPS: sized for the refrigeration load, not just the monitoring system.
Alternate storage plan: if the cold room cannot be kept running, where do products go?
Duplicate refrigeration units: WHO notes that when duplicate units are installed, mapping should include operation of each unit separately because temperature distribution can vary source.
Maintenance schedules: a well-maintained cold room fails less often. See this guide on preventive maintenance of cold rooms for a practical checklist.
Temperature Excursion Handling
A temperature excursion is any exposure outside the prescribed storage range. It does not automatically mean the product must be destroyed, but it always requires investigation.
Excursion Response Flow
Quarantine affected stock immediately if impact is unclear.
Secure the temperature record. Download data loggers and room monitoring records before anyone can overwrite or lose them.
Capture the details: start time, end time, minimum and maximum temperature, sensor identity, product batch numbers, quantities, location in the room, and likely cause.
Notify QA or the responsible person.
Contact the manufacturer or marketing authorization holder if a stability decision is needed. CDSCO’s biological GDP requires written procedures for excursions outside labelled storage conditions source.
Document disposition: release, reject, return, or continued quarantine based on QA review.
Open CAPA if a system or process failure contributed.
The “Source of Truth” Problem
Excursion disputes often happen because each party has different data. Practitioners on r/pharmaindustry report that when shipper, carrier, and receiver each run their own loggers, resolving an excursion can become slow and expensive source. In another thread, a commenter advises providing excursion data directly to the manufacturer and handling it through quality agreements and supplier complaint processes source.
Quality agreements should define:
Which sensor or logger is the official record
Whether the product logger, room logger, or vehicle logger controls disposition
Who downloads and reviews data
How conflicting data is reconciled
Response times for alarms and deviations
Documentation and Audit-Ready Records
Temperature control in a pharma cold room is as much a data integrity issue as it is a refrigeration issue. If you cannot prove it, you did not do it.
Records to maintain:
Mapping protocol and report (initial and remapping)
Calibration certificates for all sensors, loggers, and monitoring devices
Temperature logs (continuous records, reviewed and signed)
Alarm logs (including test records)
Deviation and excursion investigation reports
Maintenance logs (scheduled and unscheduled)
Cleaning and pest control records
Access and training records
Backup power test records
Electronic record audit trails
CDSCO GDP requires retention of monitoring records for at least the product shelf life plus one year source. EU GDP requires data to be protected from unauthorized modification and backed up regularly, with retention of at least five years where national legislation does not specify otherwise source.
For electronic monitoring systems, 21 CFR Part 11 requires controls including system validation, accurate record copies, limited system access, secure computer-generated time-stamped audit trails, and user training source. CDSCO GDP similarly requires validation of computers and database management systems, plus backup to prevent accidental data loss source.
Cold Room Design Factors That Affect Compliance
A pharma cold room is only as compliant as its weakest storage zone. Design choices made during construction directly determine whether the room can meet pharma cold room temperature control requirements in daily operation.
Where Cold Rooms Actually Fail
Most compliance articles say “continuous monitoring” and “alarms” but skip the places where cold rooms routinely break down:
Door openings during loading: every time the door opens, warm humid air enters. Strip curtains, rapid-roll doors, and ante-room designs reduce this.
Evaporator discharge zones: the area directly in front of the evaporator can drop well below the setpoint, freezing sensitive products.
Warm ceiling zones or high rack positions: heat rises, and the top of a tall cold room may run warmer than the middle.
Corners with poor airflow: products stacked tightly in corners may not receive adequate air circulation.
Overstocking blocking air return: loading a cold room beyond its validated capacity disrupts airflow patterns.
Products on the floor: CDSCO GDP explicitly requires off-floor storage with suitable spacing source.
Dispatch bay dwell time: products sitting in a warm loading dock between the cold room and the vehicle are exposed to uncontrolled conditions.
Defrost cycles: during defrost, the evaporator stops cooling. If the cycle runs too long or too often, temperatures can creep up.
Controller sensor mismatch: the controller may read 4°C while a product-zone sensor reads 7.5°C.
Monitoring system battery or network failure: if the logger dies, there is no record.
Sensor placed in a convenient but non-representative location: a sensor on the wall next to the door is easy to read but tells you nothing about conditions at the back of the room.
Design Considerations
Insulation and panel integrity are the first line of defense. PUF panels with proper thickness, cam-lock joints, and intact gaskets prevent thermal leaks and condensation. Panel degradation over time is a common source of slow temperature drift that mapping catches but daily observation misses.
Evaporator placement and airflow design determine whether the room can maintain uniform temperature across the validated storage volume. In high-ambient locations common across South India, condensing unit capacity must account for outdoor temperatures that can exceed 40°C.
Humidity and condensation management matter for products sensitive to moisture. WHO requires humidity monitoring systems for humidity-sensitive TTSPPs, with sensors accurate to ±5% RH and recorded at least six times per hour source.
For broader cold chain infrastructure beyond a single room, this complete guide to cold chain warehouse operations covers dispatch, receiving, and multi-commodity workflows.
Pharma Cold Room Requirements Checklist
This checklist consolidates the pharma cold room temperature control requirements discussed above into a skimmable format.
A. Before Installation or Procurement
Requirement | Why It Matters | Document to Keep |
|---|---|---|
Define product categories and labelled storage ranges | Prevents wrong storage conditions | Product label, stability data, approved specification |
Decide room type: 2°C to 8°C, CRT, frozen, or multiple zones | Determines design and equipment | User Requirement Specification (URS) |
Specify insulation, doors, evaporators, airflow, drainage, defrost | Affects temperature uniformity | URS, design drawings |
Include monitoring, alarms, backup power, access control, and data integrity in URS | Ensures compliance-ready build | URS, vendor technical proposal |
Define mapping and qualification deliverables before handover | Prevents unvalidated commissioning | Mapping protocol, qualification plan |
B. Before First Use
Requirement | Why It Matters | Document to Keep |
|---|---|---|
Complete installation checks | Confirms equipment matches specification | IQ report |
Run temperature mapping (empty and loaded) | Proves usable storage zones | Mapping protocol and report |
Identify hot spots, cold spots, no-storage zones | Prevents product damage in risky locations | Mapping report with zone diagrams |
Place routine monitoring sensors based on mapping | Ensures monitoring reflects actual risk | Sensor placement justification |
Approve mapping report and release room for use | Formal go/no-go decision | Signed approval |
C. During Routine Operation
Requirement | Why It Matters | Document to Keep |
|---|---|---|
Maintain products within labelled range | Core compliance requirement | Temperature logs |
Review temperature records at defined intervals | Catches drift before excursion | Signed review records |
Continuous monitoring and alarm escalation | Enables fast response | Alarm logs, escalation records |
Products off floor, away from walls, evaporator, doors, unmapped zones | Prevents exposure to risk zones | Loading SOP, training records |
FEFO stock rotation | Prevents expired product distribution | Inventory records |
Segregation of rejected, returned, expired, recalled stock | Prevents mix-ups | Segregation SOP, quarantine logs |
Calibration at defined intervals | Maintains data reliability | Calibration certificates |
Cleaning, pest control, maintenance | Prevents environmental failures | PPM logs, cleaning records |
D. During Alarms and Excursions
Requirement | Why It Matters | Document to Keep |
|---|---|---|
Do not ignore alarms or overwrite records | Preserves data integrity | Alarm response SOP |
Quarantine affected product if impact unclear | Protects patient safety | Quarantine log |
Capture full excursion details | Supports disposition decision | Deviation report |
Contact manufacturer if stability assessment needed | Informed product decision | Manufacturer response, stability data |
QA-approved disposition only | Ensures accountability | Signed disposition record |
Open CAPA for system or process failures | Prevents recurrence | CAPA report |
What to Include in a Pharma Cold Room URS
For procurement and project teams, the User Requirement Specification (URS) translates regulatory requirements into engineering specifications. A good pharma cold room URS should cover:
Storage temperature range and allowable operating range
Product categories and whether any are freeze-sensitive
Room dimensions and validated storage volume
Expected load and loading frequency
Ambient design conditions (local climate, seasonal peaks)
Pull-down and recovery time expectations
Evaporator and airflow arrangement
Door type, gasket, safety release, access control
PUF panel thickness and specification
Continuous monitoring and alarm requirements
Sensor accuracy and calibration requirements
Backup power or alternate storage plan
Temperature mapping, IQ/OQ/PQ, and handover documentation
Maintenance and emergency response requirements
Data retention and audit trail requirements
The cold room supplier should support the engineering and documentation inputs needed for the customer’s validation and QA process. If you are evaluating options, this walk-in cold room buyer’s guide covers the features and selection criteria worth comparing.
Common Mistakes in Pharma Cold Room Operation
These are the errors that cause audit findings, product losses, and compliance failures. Most are preventable.
Storing products in unmapped zones. If the corner near the evaporator was not mapped or was flagged as a no-storage zone, do not put products there.
Trusting the controller display instead of mapped monitoring sensors. The controller reads one point. The product sits somewhere else.
No backup plan. A power failure at 2 AM on a Sunday with no generator, no UPS, and no alternate storage is not a hypothetical.
No alarm escalation after hours. An alarm that beeps in an empty warehouse helps no one.
No written excursion procedure. When the alarm goes off, people need to know what to do immediately, not figure it out under pressure.
Putting “do not refrigerate” products into a cold room. Colder is not always safer.
Treating one mapping study as permanent after layout or equipment changes. The mapping result is valid for the configuration that was tested.
Not defining a source-of-truth logger in quality agreements. When three loggers give three readings, someone needs a predetermined answer for which one counts.
Skipping calibration. An uncalibrated sensor that reads 5°C might actually be measuring 7.8°C.
Placing sensors in convenient rather than representative locations. The sensor should sit where the risk is, not where the cable reaches easily.
Planning a Pharma Cold Room?
Getting pharma cold room temperature control requirements right starts with the build itself. The insulation, refrigeration sizing, airflow design, door configuration, and monitoring readiness all need to reflect the regulatory expectations outlined above.
F-Max Systems manufactures and installs customized cold rooms from its facility in Coimbatore, with a service network across South India. Cold rooms are built with in-house PUF panels and refrigeration units, supporting temperature ranges from +4°C down to −40°C depending on the application. For pharma projects, the cold room should be specified with mapping, monitoring, alarms, and validation documentation in mind from day one.
Discuss your pharma cold room requirement with F-Max to start the conversation around your storage range, load profile, site conditions, and compliance documentation needs. You can also explore custom cold storage solutions for more on project capabilities.
FAQ
What is the required temperature for a pharma cold room?
It depends on the product. Many refrigerated pharmaceutical products require 2°C to 8°C storage, while controlled room temperature products may require 20°C to 25°C. Frozen and ultra-low ranges apply to specific biologics and specialty products. The controlling requirement is always the storage condition stated on the product label, manufacturer instructions, and regulatory documentation.
Is 2°C to 8°C required for all medicines?
No. Some medicines are stored at controlled room temperature, some at frozen temperatures, some at ultra-low temperatures, and some should not be refrigerated at all. Storing a product at the wrong temperature, even if that temperature is “colder,” can be a deviation.
How often should temperature be recorded in a pharma cold room?
WHO recommends that cold rooms and freezer rooms provide a temperature record at least six times per hour for each monitoring sensor position source. Manual review of records should happen at least twice daily, including weekends and holidays. Local SOPs and product risk may require more frequent recording.
Is temperature mapping required before using a pharma cold room?
Yes. WHO states that all new temperature-controlled storage areas must be mapped before commissioning for TTSPP storage, and that it is not safe to store products until this is done source. EU GDP also expects initial mapping before use under representative conditions.
Where should temperature sensors be placed in a pharma cold room?
Sensors should be placed based on mapping results, at locations representing the greatest variability and the most extreme conditions (hot spots and cold spots). CDSCO GDP recommends locating monitors where fluctuations are most likely source. The control sensor and the monitoring sensor should be independent.
What happens if a pharma cold room goes out of range?
Treat it as a temperature excursion. Quarantine affected product if the impact is unclear, secure the temperature record, document the full details, notify QA, contact the manufacturer if a stability assessment is needed, and release only after QA disposition. Open a CAPA if system or process failure contributed.
Do pharma cold rooms need backup power?
For high-risk cold chain products, yes. CDSCO’s biological GDP requires backup power or alternate storage for power failure source. WHO also expects cold rooms to be connected to UPS where applicable. In regions with unreliable grid power, backup is essential.
What records are needed for a pharma cold room audit?
Mapping reports, calibration certificates, continuous temperature logs, alarm logs and test records, excursion investigation reports, maintenance logs, cleaning records, training records, and electronic data audit trail controls where applicable. CDSCO GDP requires monitoring records retained for at least the product shelf life plus one year source.
